Turpie Ag

TL;DR: The Canadian American Ticlopidine Study (CATS) as discussed by the authors is a randomized, double-blind, placebo-controlled trial to assess the effect of ticloopidine (250 mg twice daily) in reducing the rate of subsequent occurrence of stroke, myocardial infarction, or vascular death in patients who have had a recent thromboembolic stroke.

TL;DR: Serial impedance plethysmography used alone or combined with leg scanning to evaluate symptomatic patients with clinically suspected deep-vein thrombosis is an effective strategy.

TL;DR: The less intensive regimen is no less effective and safer than standard anticoagulant therapy in patients with tissue heart valve replacement and Haemorrhagic complications were significantly more frequent with standard treatment than with the lessintensive regimen.

TL;DR: Prophylaxis was started within 7 days of the onset of stroke with a loading dose of 1000 anti-factor-Xa units intravenously followed by a fixed dose of 750 anti- Factor Xa units twice a day subcutaneously; it was continued for 14 days or until hospital discharge, if earlier.

TL;DR: In this paper, the safety of non-invasive diagnostic testing for venous thrombosis was assessed in 322 symptomatic patients with impedance plethysmography and leg scanning, and the positive predictive values indicated that therapeutic decisions can be based on a positive noninvasive outcome in patients without clinical disorders known to produce false positive results.